139 related articles for article (PubMed ID: 4045892)
1. Chorea with transitional myeloproliferative disease.
Coppack SW; Gibberd FB
J R Soc Med; 1985 Oct; 78(10):864-6. PubMed ID: 4045892
[No Abstract] [Full Text] [Related]
2. Folate deficiency in the myeloproliferative disorders.
Chanarin I
Am J Clin Nutr; 1970 Jun; 23(6):855-60. PubMed ID: 5431049
[No Abstract] [Full Text] [Related]
3. Secondary gout associated with chronic myeloproliferative disorders.
Yu T; Weinreb N; Wittman R; Wasserman LR
Semin Arthritis Rheum; 1976 Feb; 5(3):247-56. PubMed ID: 1062009
[No Abstract] [Full Text] [Related]
4. [Metamorphosis of chronic myeloproliferative diseases].
Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
[No Abstract] [Full Text] [Related]
5. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
Cadiou M; Ruff F; Meunier F; Attalah N; Bernadou A; Zittoun R; Parrot JL; Bousser J
Nouv Rev Fr Hematol; 1975; 15(2):261-9. PubMed ID: 126436
[No Abstract] [Full Text] [Related]
6. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloproliferative diseases.
de Lacerda JF; Oliveira SN; Ferro JM
Handb Clin Neurol; 2014; 120():1073-81. PubMed ID: 24365372
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Sankar K; Stein BL; Rampal RK
Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
[TBL] [Abstract][Full Text] [Related]
9. Development of polycythemia vera in a patient with myeloid metaplasia and myelofibrosis. Report of a case with a comment on its significance in relation to prevailing views on myeloid metaplasia.
Hershko C; Polliack A
Isr J Med Sci; 1971 Feb; 7(2):315-20. PubMed ID: 5560987
[No Abstract] [Full Text] [Related]
10. [Pathogenesis and manifestation of disturbances of erythropoiesis and granulopoiesis in myeloproliferative syndromes].
Meuret G; Hoffmann G
Klin Wochenschr; 1972 Sep; 50(18):853-61. PubMed ID: 4562533
[No Abstract] [Full Text] [Related]
11. Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group.
Simpson-Poirier K; Harnois M; Olney HJ; Sirhan S; Gratton MO; Assouline S; Laneuville P; Delage R; Mollica L; Busque L; Szuber N
Am J Hematol; 2021 Jun; 96(6):E200-E203. PubMed ID: 33719144
[No Abstract] [Full Text] [Related]
12. Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
Martinez J; Shapiro SS; Holburn RR
Blood; 1973 Jul; 42(1):35-46. PubMed ID: 4736876
[No Abstract] [Full Text] [Related]
13. [Detection and clinical significance of JAK2 mutation in 412 patients with chronic myeloproliferative neoplasms].
Chao HY; Fan Z; Zhang R; Shen YM; Chen W; Fei HR; Zhu ZL; Feng YF; Chen ZX; Xue YQ
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):510-4. PubMed ID: 19950698
[TBL] [Abstract][Full Text] [Related]
14. Myeloproliferative neoplasms cause glomerulopathy.
Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases.
García-Manero G; Schuster SJ; Patrick H; Martinez J
Am J Hematol; 1999 Feb; 60(2):130-5. PubMed ID: 9929105
[TBL] [Abstract][Full Text] [Related]
16. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
Kaufman S; Brière J; Bernard J
Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
[TBL] [Abstract][Full Text] [Related]
17. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
18. Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders.
Talarico L; Wolf BC; Kumar A; Weintraub LR
Am J Hematol; 1989 Apr; 30(4):248-53. PubMed ID: 2929585
[TBL] [Abstract][Full Text] [Related]
19. Polycythemia vera, myeloid metaplasia with terminal myelogenous leukemia.
LITWINS J; GREENWALD L; GREENWALD HP
Bulletin NY Med Coll; 1955; 18():38-45. PubMed ID: 13329577
[No Abstract] [Full Text] [Related]
20. Uncontrolled thrombocytosis in chronic myeloproliferative disorders.
Kessler CM; Klein HG; Havlik RJ
Br J Haematol; 1982 Jan; 50(1):157-67. PubMed ID: 6976793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
